Board Member

Cooper C. Collins, MBA

Serves as Managing Partner and the CIO of MagnaSci Venture funds including advisory roles to many Pharmaceutical and Biotechnology companies.

Cooper C. Collins, MBA is a founder of Pernix Therapeutics Holdings, Inc, (PTX: NASDAQ), a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic, and OTC products.

Mr. Collins was a member of the Pernix Board of Directors since from 2007 to 2014.  Mr Collins served as President and CEO of Pernix from 2008 until May of 2013.  During his ten year career with Pernix, Mr. Collins has worked in every capacity from sales representative to the executive level.  Mr. Collins has been responsible for acquiring companies and products, attracting investors, and increasing the overall efficiency of the organization.  While serving as CEO, Mr. Collins guided the Company to over an 800% increase in sales.  In 2010, Mr. Collins was invited to ring the bell at the NYSE.  At that time, he was the youngest CEO of a publically traded pharmaceutical company in history.  Mr. Collins also serves as a Board Member and as Chairman of the Compensation Committee for TherapeuticsMD, Inc, (TXMD:NYSE MKT), a women’s healthcare company focused on developing and commercializing products targeted exclusively for women.  While serving on the board of TXMD Mr. Collins has helped the Company grow its Market Capitalization by 80 times to over $1,600,000,000.  Mr. Collins also serves on boards of privately owned companies in many sectors including defense, recycling, tech, entertainment, banking, healthcare, energy, and manufacturing.  Mr. Collins currently lives in the Houston area with his wife, Stacey, and their two children.  The Collins’s philanthropic activities are heavily weighted in favor of charities for children and veterans including participating as board member of Quick Response Foundation and Curetivity. 

Let's continue the conversation

Learn more about our Early Adopter Million-Dollar Program for the first 100 practitioners who buy eon FR. Complete the form and we will email you a brochure and specifications sheet about eon FR.

Copyright © 2019 Dominion Aesthetic Technologies, Inc. All rights reserved. This material also contains registered trademarks, trade-names and brand names of Dominion Aesthetic Technologies, Inc. and no right or license to use such names and marks is granted.